GGTI-2133, An inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 4, 2009, Pages 929-935

  Chiba, Yoshihiko ^a   Sato, S ^a   Misawa, M ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Airway inflammation; Asthma; Eosinophil; Geranylgeranyltransferase; GGTI 2133

Indexed keywords

ANTIGEN; CHEMOTACTIC FACTOR; ENZYME INHIBITOR; EOTAXIN; GERANYLGERANYLTRANSTRANSFERASE INHIBITOR; GGTI 2133; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE B4; OVALBUMIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG SELECTIVITY; ENZYME INHIBITION; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; THERAPY EFFECT; TREATMENT RESPONSE;

EID: 76349096015     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200408     Document Type: Article

References (35)

1. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-9.
2. Busse WW, Coffman RL, Gelfand EW, Kay AB, Rosenwasser LJ. Mechanisms of persistent airway inflammation. Am J Respir Crit Care Med 1995; 152:388-93.
3. Lukacs NW, Strieter RM, Kunkel SL. Leukocyte infiltration in allergic airway inflammation. Am J Respir Cell Mol Biol 1995; 13:1-6.
4. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88:935-42.
5. Tillie-Leblond I, Gosset P, Tonnel A-B. Inflammatory events in severe acute asthma. Allergy 2005; 60:23-9.
6. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333:1301-7.
7. Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2004; 117:596-606.
8. Sun D, Fernandes G.. Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production. Cell Immunol 2003; 223:52-62.
9. McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 2004; 172:2903-8.
10. Hothersall E, McSharry C, Thomson NC. Potential therapeutic role for statins in respiratory disease. Thorax 2006; 61:729-34.
11. Veillard NR, Braunersreuther V, Arnaud C, Burger F, Pelli G, Steffens S, Mach F. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis 2006; 188:51-8.
12. Vasudevan A, Qian Y, Vogt A, Blaskovich MA, Ohkanda J, Sebti SM, Hamilton AD. Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-I. J Med Chem 1999; 42:1333-40.
13. 2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice. Respir Res 2005; 6:4.
14. Chiba Y, Sato S, Misawa M. Inhibition of antigen-induced bronchial smooth muscle hyperresponsiveness by lovastatin in mice. J Smooth Muscle Res 2008; 44:123-8.
15. Chiba Y, Nakazawa S, Todoroki M, Shinozaki K, Sakai H, Misawa M. Interleukin-13 augments bronchial smooth muscle contractility with an upregulation of RhoA protein. Am J Respir Cell Mol Biol 2009; 40:159-67.
16. Chiba Y, Sato S, Hanazaki M, Sakai H, Misawa M. Inhibition of geranylgeranyltransferase inhibits bronchial smooth muscle hyperresponsiveness in mice. Am J Physiol Lung Cell Mol Physiol 2009; 297:984-91.
17. Zuckerbraun BS, Barbato JE, Hamilton A, Sebti S, Tzeng E. Inhibition of geranylgeranyltransfe rase I decreases generation of vascular reactive oxygen species and increases vascular nitric oxide production. J Surg Res 2005; 124:256-63.
18. Chiba Y, Kurotani R, Kusakabe T, Miura T, Link BW, Misawa M, Kimura S. Uteroglobin-related protein 1 expression suppresses allergic airway inflammation in mice. Am J Respir Crit Care Med 2006; 173:958-64.
19. Kim DY, Ryu SY, Lim JE, Lee YS, Ro JY. Antiinflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 2007; 557:76-86.
20. Chiba Y, Arima J, Sakai H, Misawa M. Lovastatin inhibits bronchial hyperresponsiveness by reducing RhoA signaling in rat allergic asthma. Am J Physiol Lung Cell Mol Physiol 2008; 294:L705-13.
21. Imamura M, Okunishi K, Ohtsu H, Nakagome K, Harada H, Tanaka R, Yamamoto K, Dohi M. Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung. Thorax 2009; 64:44-9.
22. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279:509-14.
23. van Aelst L, D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 1997; 11:2295-322.
24. Honing H, van den Berg TK, van der Pol SM, Dijkstra CD, van der Kammen RA, Collard JG, de Vries HE. RhoA activation promotes transendothelial migration of monocytes via ROCK. J Leukoc Biol 2004; 75:523-8.
25. van Buul JD, Hordijk PL. Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 2004; 24:824-33.
26. Worthylake RA, Lemoine S, Watson JM, Burridge K. RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol 2001; 154:147-60.
27. Martin JG, Duguet A, Eidelman DH. The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease. Eur Respir J 2000; 16:349-54.
28. Seow CY, Schellenberg RR, Pare PD. Structural and functional changes in the airway smooth muscle of asthmatic subjects. Am J Respir Crit Care Med 1998; 158:S179-86.
29. Patel CA, Rattan S. RhoA prenylation inhibitor produces relaxation of tonic smooth muscle of internal anal sphincter. J Pharmacol Exp Ther 2007; 321:501-8.
30. Shiga N, Hirano K, Hirano M, Nishimura J, Nawata H, Kanaide H. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery. Circ Res 2005; 96:1014-21.
31. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002; 3:715-20.
32. Takizawa H. Novel strategies for the treatment of asthma. Recent Pat Inflamm Allergy Drug Discov 2007; 1:13-9
33. Walsh GM. Defective apoptotic cell clearance in asthma and COPD - a new drug target for statins? Trends Pharmacol Sci 2008; 29:6-11.
34. Hothersall EJ, Chaudhuri R, McSharry C, et al. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Thorax. 2008; 63:1070-5.
35. Menzies D, Nair A, Meldrum KT, Fleming D, Barnes M, Lipworth BJ. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 2007; 119:328-35.